Psychiatry · Rio Piedras, PR
NPI
1922010065
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1056 Calle Ferrocarril
Rio Piedras, PR, 00925
Phone (787) 765-9190
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$768K
48,048 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Luis C Rojas Sr. prescribed most often to Medicare patients was Clonazepam, with 7,361 prescriptions and refills. In total Luis C Rojas Sr. wrote 48,048 Medicare prescriptions that cost $768K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-09.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Clonazepam Generic | 7,361 | 7,371 | 882 | $82K |
| Temazepam Generic | 4,698 | 4,698 | 608 | $41K |
| Lorazepam Generic | 3,608 | 3,608 | 457 | $36K |
| Trazodone Hcl Generic | 3,263 | 3,401 | 454 | $23K |
| Alprazolam Generic | 2,669 | 2,673 | 281 | $23K |
| Sertraline Hcl Generic | 2,295 | 2,409 | 323 | $14K |
| Fluoxetine Hcl Generic | 1,827 | 1,883 | 237 | $9,102 |
| Risperidone Generic | 1,826 | 1,867 | 218 | $13K |
| Zolpidem Tartrate Generic | 1,627 | 1,628 | 225 | $13K |
| Quetiapine Fumarate Generic | 1,554 | 1,640 | 174 | $15K |
| Bupropion Hcl Sr Bupropion Hcl | 1,420 | 1,485 | 197 | $13K |
| Citalopram Hbr Citalopram Hydrobromide | 1,399 | 1,494 | 185 | $6,958 |
| Estazolam Generic | 1,276 | 1,276 | 207 | $77K |
| Amitriptyline Hcl Generic | 1,183 | 1,242 | 159 | $11K |
| Paroxetine Hcl Generic | 1,156 | 1,196 | 147 | $9,716 |
Brand drugs: - claims; generic drugs: 47,508 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Luis C Rojas Sr. were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.